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REVIEW
Abstract: Conversion disorder has a history that may reach back into antiquity, and it continues
to present a clinical challenge to both psychiatrists and neurologists. This article reviews the
current state of knowledge surrounding the prevalence, etiology, and neurobiology of conversion
disorder. There have been improvements in the accuracy of diagnosis that are possibly related
to improved technologies such as neuroimaging. Once the diagnosis is made, it is important
to develop a therapeutic alliance between the patient and the medical team, and where comorbid
psychiatric diagnoses have been made, these need to be adequately treated. While there have
been no formal trials of medication or psychoanalytic treatments in this disorder, case reports
suggest that a combination of antidepressants, psychotherapy, and a multidisciplinary approach
to rehabilitation may be beneficial.
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Introduction
“Does the body rule the mind, or does the mind rule the body? I don’t know”
THE SMITHS
The relationship between mental and physical symptoms is a core tenet of psychiatry.
Egyptian physicians described cases of women suffering from unspecific symptoms:
one bed-bound; another who could not open her mouth; and a third who was “ill in
seeing”. They ascribed such symptoms to “starvation of the uterus”. These cases
were described by Veith (1965), although her interpretation of them as hysterical has
been challenged (Gilman et al 1993; Ng 1999). According to Veith, the Greek
physician Hippocrates took up this concept and coined the term “hysteria”. He
described an illness in which the uterus (in Greek: hystera) dries up and wanders the
body in search of moisture. Symptoms would then be caused by the uterus pressing
on other organs. If it had wandered as far as the cranium, for example, the symptom
would be headaches.
In modern classification systems (DSM-IV and ICD-10) the term “conversion
disorder” replaced “hysteria” some time ago. The core feature of conversion disorder
is a deficit or distortion in neurological functioning, or symptoms suggesting a general
medical condition that is not referable to an organic lesion. In both DSM-IV and
ICD-10 classifications, non-organic neurological symptoms must occur in isolation
for a diagnosis of conversion disorder to be made. Multiple symptoms are suggestive
of somatization disorder. DSM-IV lists four subtypes of conversion disorder: motor,
sensory, seizures, and mixed. Classically, presentations include motor and sensory
deficits (such as hemiparesis, paraparesis, and hemisensory loss), blindness,
swallowing difficulties (globus hystericus), and nonepileptic seizures. Presentations
can encompass any nervous system activity that is to some degree under voluntary
control and include psychogenic dementia.
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A brief history of hysteria
Prior to 1600, the hysteric affliction was linked with an
illness of the uterus (Wenegrat 2001) or given metaphysical
explanations such as witchcraft or demonic possession.
Indeed at witch trials, sensory lesions, which did not follow
known anatomical distributions, were described as “devil’s
patches” and were held to be a sign that the accused had been
consorting with the devil (Maldonado and Spiegel 2001).
By the early 17th century, a more “psychologically
minded” explanation of hysteria was introduced. Hysteria
was classified as a variety of melancholy by Robert Burton
in his Anatomy of Melancholy (Burton 1927). Thomas
Sydenham believed that both men and women could suffer
from hysteria, which he considered an affliction of the mind,
and the Scottish physician Robert Whytt wrote a book
entitled Nervous, Hypochondriac and Hysteric Disorders,
which classified hysteria as a nervous disorder (Whytt 1768).
This concept was further developed by Jean Martin
Charcot in the 19th century at the Salpêtrière in Paris. He
described a syndrome of “hysteria major” (similar to the
modern condition of nonepileptic seizures) and hypnotized
patients to facilitate the presentation of their symptoms. This
technique influenced Freud and Breuer’s (1905) publication
Studies on Hysteria. Breuer treated a young Viennese woman
who he called Anna O who suffered from convergent squint,
paralyses, paresis of her neck muscles, and contractures.
The patient could enter a state of autohypnosis in which,
with Breuer’s help, she could provide detailed accounts of
the circumstances in which each individual symptom had
begun. After this, that particular symptom would abate. Anna
O famously named this the “talking cure” (Freud and Breuer
1974).
The term conversion derives from this psychoanalytic
tradition and reflects the emergence of physical symptoms
as an attempt to resolve, or to communicate, unconscious
and unbearable psychic conflicts – to “convert” them from
psychic symptoms to physical ones. In clinical situations, it
is often difficult to pinpoint a relevant psychological stressor,
and Freud’s notional association of these symptoms with the
repression of sexual desire remains controversial. However,
Roelofs et al (2002) assessed 54 patients with conversion
disorder and a comparison group of 50 patients with affective
disorder and found that those with conversion disorder
reported a higher incidence of physical and sexual abuse.
The epidemiology of conversion
Conversion disorder is a relatively common presentation in
neurological practice, accounting for perhaps 1%–3% of
diagnoses in general hospitals (Marsden 1986) and more in
specialist neurological settings (Ron 1994). Carson et al
(2003) found that 30% of new attendees at neurology
outpatient clinics had “medically unexplained symptoms”,
a category that includes, but is not synonymous with,
conversion disorder. When followed up 8 months later, over
half were still troubled by their symptoms and had not
improved. No cases developed a neurological diagnosis.
In primary care, conversion disorder is less common.
Singh and Lee (1997) surveyed primary care physicians and
identified 18 patients (out of a catchment population of
37 000) with conversion symptoms. They found an
association with female gender and a history of childhood
sexual abuse.
The neurobiology of conversion
disorder
The development of functional neuroimaging techniques has
provided the methodology to study the neural basis of
conversion disorders. Using positron emission tomography
(PET), Marshall et al (1997) found increased cerebral blood
flow in the right anterior cingulate and right orbitofrontal
cortex in a patient with a hysterical left hemiparesis. Spence
et al (2000) found deactivation of the left dorsolateral
prefrontal cortex (DLPFC) in subjects with hysterical
hemiparesis, regardless of the side of the deficit. Maruff
and Velakoulis (2000) compared a patient with hysterical
paralysis with normal controls in generating motor imagery
(performing a movement in imagination), and they found
the ability to generate motor plans was preserved in the
conversion patient. It is possible therefore that these
alterations in frontal function are related not to a deficit
within the neural network but rather to an action of the “will”
in inhibiting movements.
Using SPECT scanning, Vuilleumier et al (2001) studied
7 patients with hysterical unilateral sensorimotor
impairment. They showed reduced blood flow in the
thalamus and basal ganglia contralateral to the deficit which
resolved after recovery of the symptoms. They suggest that
conversion symptoms may involve striato-thalamo-cortical
circuits, which would tie in with the known roles of such
circuits in the emotional moderation of motor processes.
Emotional stressors could inhibit these pathways, thus
impairing motor readiness and affect the quality of
voluntary movements. Interestingly, these circuits are also
involved in the unilateral sensorimotor neglect, which
occurs after neurological lesions, and in which the affected
limb is not paralyzed, but is not under voluntary control.Neuropsychiatric Disease and Treatment 2005:1(3) 207
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Striato-thalamo-cortical loops are involved in many
processes, and might also plausibly underlie non-motor
conversion symptoms such as memory loss.
Unlike functional imaging findings, evoked motor and
somatosensory potentials have in the past been reported as
normal in conversion disorders (Meyer et al 1992). However,
two cases reported recently by Yazici et al (2004) showed
greatly diminished somatosensory evoked responses while
symptoms were present, with a return to normal after
conversion symptoms had abated. Additional studies are
clearly required to elicit the neural correlates of conversion.
Diagnosis of conversion disorder
The diagnosis of conversion disorder is a clinical challenge.
A careful psychiatric history and examination should be
taken to screen for comorbid psychiatric illness, and if
identified these should be treated appropriately. The
psychiatric history is required also to elucidate the onset
and nature of symptoms and the presence of stressors,
although in many cases a psychological reason is elusive
(Ron 2001). This may be because a patient with conversion
symptoms is not often able to explain psychological factors
themselves – this being the reason that they need (albeit
unconsciously) to express them as bodily symptoms.
Early in a patient’s presentation, physical investigations
may be undertaken to exclude general medical conditions.
While conversion disorder should not be considered a
diagnosis of exclusion, in clinical practice the patient
often undergoes multiple physical examinations and
investigations. A consequence of this is that patients may
be given a psychiatric diagnosis as a last resort when all
else has failed. The process of serial medical investigation
may not allay fears, and may exacerbate anxiety in some
patients.
While it has only a limited role as a diagnostic tool,
historical information such as childhood experience,
personality style, illness beliefs, and “secondary gain” can
influence the quality of the patient’s experience (Stone et al
2002). Crimlisk et al (1998) encourage doctors to make a
positive diagnosis early to avoid creating uncertainty and
reduce the need for costly and unnecessary investigations.
The possibility of introducing a psychiatrist early in the
process of diagnosis – perhaps in the neurology clinic –
might be of benefit. Demonstration of the physical signs to
the patient may be therapeutically helpful, and may help to
explain that under certain circumstances their nervous
system is capable of functioning normally. This also
promotes trust in the doctor – patient relationship (Stone et
al 2002).
According to DSM-IV, conversion symptoms must be
of clinical significance to the patient, or of social or
occupational consequence. While for some patients the
benefits of the “sick role” may result in perceived significant
gain (Ron 2001), the associated handicaps are often great
(Vuilleumier et al 2001). Factitious disorder (the conscious
production of symptoms in pursuit of medical attention) or
malingering (the conscious production of symptoms and
signs for financial or material gain) are distinct from
conversion disorder. Stone et al (2002) suggest that
physicians have a tendency to overdiagnose feigning of
symptoms: in clinical practice the distinction between
conversion and factitious disorders can only be considered
definitive if corroborated by covert surveillance or
confession.
An apparent lack of distress in the face of unpleasant
symptoms or even disability – “la belle indifference” – is
classically associated with conversion symptoms. This is
held to be a useful diagnostic sign, but is not a common
feature, and the majority of patients with conversion
symptoms are in fact distressed by them (Stone et al 2002).
A core feature of the diagnosis of conversion disorder is
the absence of a neurological or organic diagnosis. Slater
(1965) famously undertook a 10-year follow-up study of
patients diagnosed with hysteria and reported that half of
his patients developed clear neurological or psychiatric
conditions, indicating a high rate of misdiagnosis. However,
a more recent study (Crimlisk et al 1998) reviewed 73
consecutive patients with neurologically unexplained
symptoms and found, in contrast to Slater, a low incidence
of neurological conditions that might have explained their
initial symptoms (3 out of 69 patients). Seventy-five percent
of their sample had a psychiatric diagnosis (predominantly
affective, anxiety, or somatization disorders) at presentation,
and 45% were diagnosed with a personality disorder. In a
follow-up study by Binzer and Kullgren (1998), none of
the 30 patients with conversion disorder was subsequently
reclassified as suffering from a neurological disease. Similar
findings were reported by Carson et al (2003) who followed
up a cohort of neurology clinic attendees whose symptoms
were rated as “not at all” or only “somewhat” related to an
organic disease. None of the 66 people followed up had
acquired an organic diagnosis at eight months. Fourteen
percent of the participants rated their condition as “worse”,
40% rated it “the same”, and 46% had subjectively
improved. These results may be biased by the relatively smallNeuropsychiatric Disease and Treatment 2005:1(3) 208
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sample size (90 patients) and drop out of cases, such that
73% of the cohort was reassessed at eight months. Stone et
al (2003) in a 12-year follow up reported that 83% of patients
had no change in diagnosis, but that 29% had retired early
on medical grounds. To our knowledge the only prospective
study was undertaken by Binzer and Kullgren (1998) who
reviewed 30 individuals with motor conversion disorder over
a period of 2–5 years. At follow-up, 19 patients had
completely recovered, with only 3 being unchanged or
worse. It is possible that this apparent “better outcome” in
later studies is related to both improvement in the diagnosis
of neurological conditions (particularly using neuroimaging
techniques) and the reclassification of disorders such as the
dystonias as neurological conditions. An additional
confound for these studies is a small sample size, which
leads to difficulties in ascertaining the true incidence and
prevalence and natural history of the condition.
Acknowledging the limitations of sample size of these
studies there are factors associated with good prognosis that
include male gender, acute onset, a short duration of
symptoms, an acute precipitating event, change in marital
status (either marriage or divorce), premorbid psychiatric
diagnosis, good premorbid health, and the absence of a co-
existing medical condition. In contrast, poor prognosis is
associated with subclinical personality pathology, co-
existing medical illness, poor perception of their own
wellbeing, and a high score on the Beck Hopelessness Scale
and pending litigation. In children, conversion symptoms
may remit spontaneously. Pehlivanturk and Unal (2002)
found that 85% of children with conversion disorders
recovered completely at 4 years, and another 5% had shown
some improvement. Indicators of a good prognosis included
early diagnosis and good premorbid adjustment. There may
be an additional effect related to the clinical nature of
conversion disorder. Patients who had sensory symptoms
at presentation tended to have a better outcome than those
who had presented with weakness (Crimlisk et al 1998),
while up to one third of globus hystericus cases may become
chronic (Finkenbine and Miele 2004). At 10-year follow-
up, 30/56 patients assessed by Mace and Trimble (1996)
were still troubled by their presenting symptoms.
Clinical approaches to the
treatment of conversion disorder
Hypnosis
There are limited case reports of clinical improvement
following hypnosis (see Singh and Lee 1997). On balance,
however, the authors do not feel that these provide an
evidence base from which to support the use of hypnosis.
Psychotherapy
The cornerstone of treatment of conversion disorders is
psychotherapy aimed at elucidating the emotional bases of
the symptoms. A multidisciplinary approach to rehabilitation
may be beneficial (Moene et al 2002; Wald et al 2004). While
the evidence base for these therapies is limited, success has
been claimed with psychoanalysis, cognitive behavior
therapy (CBT), behavior modification, and family therapy.
The successful use of CBT in other medically unexplained
conditions such as chronic fatigue syndrome (Whiting et al
2001) make this is a potential area for further research.
Medication
There is little evidence to guide pharmacotherapy in
conversion disorder, and in the UK there are no NICE
(National Institute for Clinical Excellence) guidelines
available at present. The clinical evidence for pharmaco-
therapy in conversion disorder is extremely limited and
consists of case reports. Thus, therapeutic success has been
reported with haloperidol (Masuda et al 2003), tricyclic
antidepressants (Cybulska 1997), and ECT (Cybulska 1997;
Yazici et al 2004). These studies serve to emphasize the
importance of screening for comorbid psychiatric
conditions.
Conclusions
Despite recent advances in our understanding of the
epidemiology, etiology, and treatment of common
psychiatric disorders, our understanding of conversion
disorder remains limited. The literature reveals there is a
limited knowledge regarding the incidence and prevalence
of this condition, but studies in cohorts of patients from
specialist services suggest that psychiatrists are improving
their ability to identify cases of conversion disorder. While
not supporting the notion of a “diagnosis of exclusion”
regarding physical illness, it is important to identify and
treat any comorbid psychiatric illness that may affect the
ultimate outcome. The neuroimaging findings of altered
prefrontal functioning suggest that this condition may be
sensitive to drug treatments, which can modify neural
activation in these areas. A combination of treatment with
antidepressant medication and appropriate psychotherapy
and multidisciplinary rehabilitation focusing on improving
the patient’s level of functioning and reducing theirNeuropsychiatric Disease and Treatment 2005:1(3) 209
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subjective distress may be the most effective treatment at
present. There is a clear need for further systematic research
in this area.
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